Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 932-235-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Remarks:
- based on generations indicated in Effect levels (migrated information)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- not stated
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Read across from dodecanol (CAS 112-53-8). Comparable to guideline study (draft guideline) with acceptable restrictions.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Draft OECD 422 Combined Repeat dose and Reproductive/Developmental Toxicity Screening Test.
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Dodecan-1-ol
- EC Number:
- 203-982-0
- EC Name:
- Dodecan-1-ol
- Cas Number:
- 112-53-8
- IUPAC Name:
- dodecan-1-ol
- Details on test material:
- - Name of test material (as cited in study report): 1-Dodecanol
- Substance type: no data
- Physical state: no data
- Analytical purity: 99%
- Impurities (identity and concentrations): no data
- Composition of test material, percentage of components: no data
- Isomers composition: no data
- Purity test date: no data
- Lot/batch No.: no data
- Expiration date of the lot/batch: no data
- Stability under test conditions: no data
- Storage condition of test material: no data
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Moellegard breeding centre
- Age at study initiation: F 8 weeks, M 7 weeks
- Weight at study initiation: no data
- Fasting period before study: no data
- Housing: 2/cage, steel wire cages type 3 (up to day 20 of gestation); macrolon cages type 3 (from day 20 of gestation)
- Diet (e.g. ad libitum): IT chow 101, presumably ad libitum
- Water (e.g. ad libitum): acidified tapwater, ad libitum
- Acclimation period: 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +- 2
- Humidity (%): 55 +- 10
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: no data
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- DIET PREPARATION
- Rate of preparation of diet (frequency): no data
- Mixing appropriate amounts with (Type of food): IT chow 101
- Storage temperature of food:no data
- Preparation procedure: Diet preparation involved first mixing an aqueous dodecanol solution with the barley component, which varied for each dose level. The other components of the diet were then added. - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: 14 days
- Proof of pregnancy: vaginal plug recorded during the morning referred to as day 1 of pregnancy; vaginal plug recorded at lunch time or during the afternoon referred to as day 0 of pregnancy
- After 14 days of unsuccessful pairing replacement of first male by another male for up to 8 days
- Further matings after two unsuccessful attempts: no
- After successful mating each pregnant female was caged (how): in steel wire cages type 3 until day 20 of pregnancy, placed in macrolon cages type 3 thereafter
- Any other deviations from standard protocol: none - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- Exposure period: Males 41-44 days , females up to 54 days
Premating exposure period (males): 14 days
Premating exposure period (females): 14 days
Duration of test: Males 41-44 days, females up to 54 days - Frequency of treatment:
- continuous in diet
- Details on study schedule:
- - One-generation study (only parental animals mated)
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 1500, 7500 & 30,000 ppm (approx 100, 500, 2000 mg/kg bw/day)
Basis:
nominal in diet
- No. of animals per sex per dose:
- 12
- Control animals:
- yes, plain diet
- Details on study design:
- - Dose selection rationale: preliminary test via a dermal route
- Rationale for animal assignment (if not random): 2 days prior to the start of dosing, animals randomised into four groups with same mean body weight - Positive control:
- none
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
- Cage side observations included: mortality
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT: Yes
- Time schedule for examinations: males once per week; females premating once per week
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption in g body weight gain/kg food per week calculated from the consumption and body weight gain data: Yes
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No - Oestrous cyclicity (parental animals):
- no data (exposure was for 14 days premating covering at least 2 oestrous cycles; ovaries were weighed and examined histopathologically at necropsy)
- Sperm parameters (parental animals):
- Parameters examined in male parental generation: testis weight, epididymis weight
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: no (one-generation screening study)
PARAMETERS EXAMINED
- The following parameters were examined in F1 offspring: number of pups on days 1, 4 and 5; sex of pups on day 5; postnatal mortality from day 1 to day 4; weight gain from day 1 to day 4; mean body weight of male and female pups on day 5; presence of gross abnormalities on day 5
GROSS EXAMINATION OF DEAD PUPS: yes, on day 5, for external abnormalities including the head (especially the eyes and cleft palate), abdomen and thoracic cavity examined internally for malformations; possible cause of death was not determined for pups born or found dead - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals after 41-44 days of dosing
- Maternal animals: All surviving animals on day 5 after birth
ORGAN WEIGHT: males - liver, kidneys, thymus, testes, epididymides; females - liver, kidneys, thymus
ORGANS FIXED IN FORMALIN: males - liver, kidneys, adrenals, brain, heart, spleen, thymus, organs with pathological changes, testes and epididymides fixed in Bouin's solution; females - liver, kidneys, adrenals, brain, heart, spleen, ovaries, thymus, other organs with observed pathological changes
HISTOPATHOLOGY: Yes, control and top dose group, all fixed organs except thymus - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring not selected as parental animals and all F2 offspring were sacrificed at [#?] days of age: not applicable (1-generation study) - Statistics:
- Using the SAS-stat program; analysis of variance; all statistically significant findings further evaluated by Dunnett's t-test; chi-squared test for pregancy rate
- Reproductive indices:
- pregnancy rate; length of gestation; numbers of corpora lutea, implantations, resorptions and pups at birth
- Offspring viability indices:
- number of pups at birth and on days 4 and 5, number of pups per litter, pup deaths between days 1 and 4
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- not examined
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
Details on results (P0)
- Mortality and time to death: None
- Clinical signs: None reported
BODY WEIGHT AND WEIGHT GAIN
- Body weight gain: No differences between treated and controls of either sex.
TEST SUBSTANCE INTAKE (PARENTAL ANIMALS)
Males: 102.4, 530.8 and 2046.4 mg/kg bw/day (mean of values reported for 2 weeks prior to mating and 3 weeks after mating)
Females: 130.5, 657.5 and 2870.5 mg/kg bw/day (mean of values reported 2 weeks prior to mating)
REPRODUCTIVE FUNCTION: ESTROUS CYCLE (PARENTAL ANIMALS)
no data
REPRODUCTIVE FUNCTION: SPERM MEASURES (PARENTAL ANIMALS)
no data
REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
- no statistically significant effects on pregnancy rate, length of gestation or numbers of corpora lutea, implantations, resorptions or pups at birth
- pregnancy rate was reduced in treated groups: 0 mg/kg bw/day 92%, 100 & 500 mg/kg bw/day 83%, 2000 mg/kg/day 75%; these were within the normal historical control range according to the investigators (actual historical control data not presented); lack of statistical significance confirmed using chi-squared test
- mean length of gestation: 23 days in all groups
- mean number of corpora lutea: 14 in all groups
- mean number of implantations: 13 in controls, 14 in all treated groups
- no resorptions in any group
ORGAN WEIGHTS (PARENTAL ANIMALS) (see table 2)
- There were no dose related changes in organ weights, including the testes, epididymides and ovaries; in males only there was a reduction in relative and absolute liver weights at the low dose level and a reduction in relative liver weight at mid doses, the top dose was comparable to controls.
GROSS PATHOLOGY (PARENTAL ANIMALS)
- There were no changes attributable to exposure to the test compound.
HISTOPATHOLOGY (PARENTAL ANIMALS)
- There were no treatment related histopathological changes.
OTHER (PARENTAL ANIMALS)
- Haematology and clinical chemistry data for parental males (reported elsewhere)
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- 2 000 mg/kg bw/day (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: Dietary concentrations of 1500, 7500 and 30000 ppm provided nominal dose levels of 100, 500 and 2000 mg/kg bw/day
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not examined
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
Details on results (F1)
- no statistically significant effect
- litter size mean on day 1: controls 13.25, low dose 13.27, mid dose 13.2, high dose 13.33.
CLINICAL SIGNS (OFFSPRING)
- no effects
BODY WEIGHT (OFFSPRING)
- no statistically significant effects
- mean litter weights at day 1 were 75, 75, 71 and 77 g and at day 4 106, 107, 101 and 104 g for control, low, mid and high dose respectively
SEXUAL MATURATION (OFFSPRING)
- not applicable (1-generation screening study)
ORGAN WEIGHTS (OFFSPRING)
- not applicable (1-generation screening study)
GROSS PATHOLOGY (OFFSPRING)
- no effects
HISTOPATHOLOGY (OFFSPRING)
- no data
OTHER FINDINGS (OFFSPRING)
- no statistically significant effects on pup body weight on day 5
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 2 000 mg/kg bw/day (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: Dietary concentrations of 1500, 7500 and 30000 ppm for parental animals provided nominal dose levels of 100, 500 and 2000 mg/kg bw/day
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Read across from dodecanol (CAS 112-53-8) was obtained in a reliable study conducted to the draft OECD guideline 422. A parental NOAEL of 2000 mg/kg bw/day (highest dose tested) was determined for male and female rats. No adverse effects were observed on reproductive parameters and the NOAEL for reproductive and developmental effects was also 2000 mg/kg bw/day. The study was performed in compliance with GLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.